Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas
about
Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functionsAcromegaly pathogenesis and treatmentPituitary adenomas: historical perspective, surgical management and future directionsMEG3 noncoding RNA: a tumor suppressorThe molecular pathogenesis of pituitary adenomas: an updateMicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancerMaternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progressionThe Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung AdenocarcinomaExpression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb PathwayIncreased expression of angiogenic genes in the brains of mouse meg3-null embryosHuman cancer long non-coding RNA transcriptomes.Identification of somatic mutations in parathyroid tumors using whole-exome sequencingNewborns of obese parents have altered DNA methylation patterns at imprinted genes.Identification of sexually dimorphic genes in the neonatal mouse cortex and hippocampusThe FGFR4-G388R polymorphism promotes mitochondrial STAT3 serine phosphorylation to facilitate pituitary growth hormone cell tumorigenesisMicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas.Anterior pituitary adenomas: inherited syndromes, novel genes and molecular pathways.The role of epigenetic modification in tumorigenesis and progression of pituitary adenomas: a systematic review of the literature.Concomitant downregulation of the imprinted genes DLK1 and MEG3 at 14q32.2 by epigenetic mechanisms in urothelial carcinomaSilencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomasLong noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets.Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer.Depression in pregnancy, infant birth weight and DNA methylation of imprint regulatory elementsTumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line.Lateral ventricle injection of orexin-A ameliorates central precocious puberty in rat via inhibiting the expression of MEG3Long non-coding RNA in cancer.Isoform switching and exon skipping induced by the DNA methylation inhibitor 5-Aza-2'-deoxycytidine.Pituitary phenotypes of mice lacking the notch signalling ligand delta-like 1 homologue.Long non-coding RNAs in haematological malignancies.Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenomaIsolation and characterization of novel pituitary tumor related genes: a cDNA representational difference approach.Large non-coding RNAs: missing links in cancer?Molecular mechanisms of genomic imprinting and clinical implications for cancer.The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine.MEG3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas.LncRNAs: new players in gliomas, with special emphasis on the interaction of lncRNAs With EZH2.Long noncoding RNAs: a potential novel class of cancer biomarkers.Long non-coding RNAs and complex diseases: from experimental results to computational models.Transcriptome analysis of MENX-associated rat pituitary adenomas identifies novel molecular mechanisms involved in the pathogenesis of human pituitary gonadotroph adenomas.Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications
P2860
Q24623420-8281E8A1-433C-4019-92E4-144A94222DECQ24647360-6BB387A7-1F84-4A6D-AC7F-6AAE0C9B5FBDQ26779749-E1D5F75D-7EB2-4498-8DDA-0A82406B1AADQ26823948-6B7D3F79-F02F-420A-B904-63594713B894Q26830047-3A114809-048C-493F-ACA1-5180934B99EFQ27022048-51C48285-70DC-4F3D-A305-92F2848B6F92Q28115872-C410F5E7-5CFD-415B-9266-862D74D2D6E8Q28547372-40008B43-5EC4-44F1-BE33-EAA9C15D4A28Q28553467-3BCBE5CC-12E5-45BA-92D5-A4A179A4A3A1Q28590418-78A487DE-ADE9-47FA-990E-0A2748191652Q31032840-8477A11C-E567-4D3B-849A-ECE7ABAD89FAQ33569943-0FC25D19-3FBC-4E65-AEEC-E1CC00005D30Q33721781-BF51E2A2-5AD5-4B6D-8B17-C6A14403CBBAQ33758560-A55E028F-DA9C-47AD-9BC0-598518B8C1BFQ34102786-38E60F6E-635E-4BDB-8D97-C3159AEB4BF9Q34148960-579F4438-1B62-4E5F-942E-FAB7DB156256Q34508504-E432CF25-BE1A-4DF1-9587-E91B8A5EF4ABQ35075351-C9D97D96-CDD7-4356-A52D-6BEA029207D5Q35142587-3D263C22-5EC9-4229-A93A-045FD5299563Q35235761-067EB59A-07E4-4359-B7E1-0FC32D7BD115Q35747814-BB5B7F94-6E2D-43A8-8BCF-2F85011B1F51Q35964148-58F6EE38-4322-47A6-AE8F-C8332401859FQ36149236-BADAA179-422F-4AAB-84BE-C377DC8111AFQ36161900-BA788266-F354-4ECC-8EC5-E925E5A9EEFEQ36375156-C1A56C85-DAAD-4364-890C-0F03790AE5AEQ36790436-59AE8006-F536-4734-A6DF-7556B37CE7BAQ36810277-98A7CF1E-23CD-4297-A5B6-A8F7D81E6CD9Q36876889-89F5A13E-F302-47B5-9A5B-EF97FB47DB79Q37139037-C95F022D-0248-42B7-8248-7551EB020506Q37619445-FAA95A77-2725-44E1-B3DE-AC92203883FAQ37704785-C78C50E6-9897-483D-A578-247531965D6EQ37781625-DD1273BF-7B4F-41B9-8AD3-6E58213BDB9BQ37831991-8D910BEB-4B32-4842-A2C5-BE5880765C5CQ38045210-F7DA8678-51DF-4957-A2DA-58E21B04045FQ38073178-8DB1953B-FA30-4CD5-9650-26146E00151BQ38176848-8D76F983-3591-4EED-86A9-A6E1C42B14A0Q38466810-74271361-EF8D-4356-84E6-57B9D31E6D62Q38848384-CF403A3E-6216-4795-9D68-578207B5706FQ39140897-919C266D-A411-43CF-85F5-157FBD7DFCE0Q41608473-2A3725B7-4D21-4BD0-88ED-45B9E8ACC892
P2860
Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas
description
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
im Oktober 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/10/01)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/10/01)
@nl
наукова стаття, опублікована в жовтні 2008
@uk
مقالة علمية (نشرت في أكتوبر 2008)
@ar
name
Selective loss of MEG3 express ...... functioning pituitary adenomas
@ast
Selective loss of MEG3 express ...... functioning pituitary adenomas
@en
Selective loss of MEG3 express ...... functioning pituitary adenomas
@nl
type
label
Selective loss of MEG3 express ...... functioning pituitary adenomas
@ast
Selective loss of MEG3 express ...... functioning pituitary adenomas
@en
Selective loss of MEG3 express ...... functioning pituitary adenomas
@nl
prefLabel
Selective loss of MEG3 express ...... functioning pituitary adenomas
@ast
Selective loss of MEG3 express ...... functioning pituitary adenomas
@en
Selective loss of MEG3 express ...... functioning pituitary adenomas
@nl
P2093
P2860
P3181
P356
P1476
Selective loss of MEG3 express ...... functioning pituitary adenomas
@en
P2093
Brooke Swearingen
Dalia L. Batista
E. Tessa Hedley-Whyte
Roger Gejman
Ying Zhong
Yunli Zhou
P2860
P304
P3181
P356
10.1210/JC.2007-2633
P407
P577
2008-10-01T00:00:00Z